NeuroVision Imaging Inc. announces the acquisition of Durin Life Sciences Inc., creating an integrated neurodegenerative disease diagnostics and care platform focused on advancing earlier detection, patient access, and longitudinal brain health management. The transaction combines Durin’s blood-based biomarker diagnostics platform with NeuroVision’s retinal imaging technology, telehealth infrastructure, and BrainHealth.net patient engagement platform. Together, the companies aim to accelerate the development and commercialization of innovative diagnostic solutions for Alzheimer’s disease, Parkinson’s disease, amyotrophic lateral sclerosis (ALS), and related neurological disorders.
Read the full article: NeuroVision Acquires Durin Life Sciences to Advance Earlier Detection and Management of Neurodegenerative Disease //
Source: https://www.businesswire.com/news/home/20260512849966/en/NeuroVision-Acquires-Durin-Life-Sciences-to-Advance-Earlier-Detection-and-Management-of-Neurodegenerative-Disease